Retraction notice to “Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo” [Biochem. Pharmacol. 79 (2010) 330–338]
Preetha Ananda,1, Hareesh B. Nairb,1, Bokyung Sunga, Ajaikumar B. Kunnumakkaraa, Vivek R. Yadava, Rajeshwar R. Tekmalb, Bharat B. Aggarwala,*
a Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 143, Houston, TX, United States
b Department of Obstetrics and Gynecology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
This article has been retracted at the request of the Editor.
Images from Fig. 2A were reused in Fig. 5A of Ref. [1] to represent different experimental conditions: four of the control images of cellular uptake of curcumin shown in Fig. 2A (45, 60, 120 and 180 min) are also shown in Fig. 5A (45, 60, 120 and 180 min) of Ref. [1].
The article has been retracted because the data integrity has become questionable.
* Corresponding author. Tel.: +1 713 794 1817; fax: +1 713 606 3399. aggarwal@mdanderson.org (B.B. Aggarwal).
1 Both authors contributed equally to this study.
References
- [1].Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, Vaahtera L, Parkkinen J, Aggarwal BB. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem. Pharmacol. 2010;80:1021–1032. doi: 10.1016/j.bcp.2010.06.022. doi: http://dx.doi.org/10.1016/j.bcp.2010.06.022. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]